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132 Non-respiratory swabs have little role in the detection of
methicillin resistant Staphylococcus aureus in cystic ﬁbrosis
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K. Webb1, A. Jones1. 1Manchester Adult CF Centre, Manchester, United
Kingdom; 2University Hospitals of South Manchester, Dept of Microbiology,
Manchester, United Kingdom
Background: Chronic methicillin resistant Staphylococcus aureus (MRSA) infec-
tion in CF is associated with faster FEV1 decline and greater mortality. Screening
for infection involves swabs from both upper respiratory (nose, throat) and periph-
eral sites (groin, axilla), as well as sputum culture. There are no data to indicate
which is superior.
Methods: Microbiology results of pts attending our adult tertiary care centre
who have had any positive MRSA result between 01/01/09 and 01/08/2010 were
reviewed. Patients were considered continuously infected between their earliest and
last MRSA culture.
Results: 17pts (5%) had at least 1 MRSA isolate: 6 known chronic MRSA; 3
intermittent; 6 detected on routine outpatient sputum culture; 2 detected on ward
screening.
307 microbiology samples were taken during periods of MRSA positivity:
180 (59%) were swabs (throat = 71, nose = 35, groin = 59 and axilla = 15) and 127
sputa. Of these, 70 (55%) sputa were MRSA positive. Nose swabs grew MRSA in
24%, throat 23%, groin 19% and axilla 0% cases.
28 sets of concurrent samples from 12 pts were discordant. Nose swabs were positive
in 17/28 (61%) of these, throat swabs in 8/14 (57%). Peripheral swabs grew MRSA
in 5/27 (19%), all also positive in nose +/− sputum. Concurrent sputa were MRSA
positive in 15/23 (65%).
Discussion: Upper respiratory tract swabs constitute an important tool for MRSA
surveillance. Little additional information however is derived from non-respiratory
swabs, and their routine use could be discontinued in units with low MRSA
prevalence. In those who expectorate easily, sputum is the most effective method of
detecting MRSA. There is a considerable false negative rate for all sample methods.
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Background: Prevalence of methicillin resistant Staphylococcus aureus (MRSA)
in CF has increased to ~22% in the US. This parallels rises of healthcare associated
MRSA (HA-MRSA) and MRSA in the community (CA), especially strain USA300
(SCCmecIV PVL+). This study examines the prevalence of HA- vs. CA-MRSA
based on molecular typing; antimicrobial susceptibility testing (AST) and patient
characteristics at seven US CF centres.
Methods: MRSA isolates are collected randomly from paediatric CF patients and
are typed by SCCmec and pvl status. AST is done using VITEK2 GP67 card and
Etest for fusidic acid, fosfomycin and mupirocin according to US and European
Microbiological Guidelines. Clinical data are obtained from the US CFF Patient
Registry.
Results: Of 299 MRSA isolates, 69% (range 63−83%) are SCCmecII (HA-MRSA).
The remaining isolates are SCCmecIV of which 57% are pvl positive. Resistance
(R) is ~90% for erythromycin for all molecular types; Antibiotics with least R were
TMP-SMX (3−10%), tetracyclines (4−8%) and fusidic acid (0−5%). Clindamycin
R is high in HA and low in SCCmecIV strains. No isolates are resistant to
vancomycin and 1/299 each resistant to linezolid or tigecyclcine. Mupirocin R
was 8% in CA- and 0 in HA-MRSA. Presently clinical information is available
on 193 patients showing a mean age of 11.5 ± 4.7 years and 71% with chronic
P. aeruginosa.
Conclusion: In the US, about 1/3 of MRSA strains among paediatric CF patients
are SCCmecIV of which half are pvl positive. Despite ample use resistance to
TMP-SMX is low but ﬂuoroquinolone R high in HA-MRSA. Although not being
approved in the US sporadic resistance to fosfomycin and fusidic acid occurs. Link
to demographic data for all patients is ongoing.
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Background: Recent studies have shown that MRSA is associated with of worse
survival in CF patients. The role of a different genetic background in community-
acquired (CA-MRSA) and hospital-acquired (HA-MRSA) strains in this process
remains unclear. There is no evidence of the preponderant role that particular clones
might have in worsening CF patients conditions.
Aim: The aim of this study was to analyze MRSA strains responsible for ﬁrst
infections of CF airways, and determine their genetic background.
Materials and Methods: 42 strains infecting for the ﬁrst time the airways of 42
CF patients were collected and analyzed determining SCCmec type and sequence
type as previously described (Oliveira and de Lancastre, 2002 and Enright et al,
2000).
Results: Twenty (47.6%) out of 42 strains belong to CA-MRSA, the remaining 22
(52.4%) to HA-MRSA. MLST analysis, performed on 24 out of 42 strains, showed
the presence of already described clones, including ST8-MRSA-IV, ST228-MRSA-I
or Southern Germany clone, and ST45-MRSA-IV or Berlin clone.
Conclusions: Our study suggests that the prevalence of CA-MRSA and HA-MRSA
is comparable and demonstrates that known epidemic clones are responsible for ﬁrst
infection. Further studies are needed to clarify the role of these clones on clinical
status of CF patients.
This work was supported by Italian Cystic Fibrosis Research Foundation (grant
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CF patients are susceptible to respiratory tract infection with a variety of bacterial
species including species belonging to the genera Burkholderia and Ralstonia. The
role of Burkholderia in contributing to pulmonary disease in CF is well known,
whereas little is known about the relevance of Ralstonia. This is also due to the
difﬁcult identiﬁcation of Ralstonia species, which are frequently misidentiﬁed as
other closely related species.
Thus, the aim of this work was to set up a diagnostic method to identify Ralstonia
and Burkholderia strains by applying a new molecular strategy based on the use of
nested overlapping genes. To this purpose, we focused on genes of the histidine (his)
operon, because the analysis of 1098 genomes revealed the insertion of marC,
a gene unrelated to his biosynthesis, within his operon, whereby marC partially
overlaps with hisH only in all strains belonging to these two genera. Hence, three
forward PCR primers (one speciﬁc for Burkholderia, one for Ralstonia and one for
both genera) targeting marC and one reverse primer targeting hisH were designed.
The three primer sets were tested on 35 Burkholderia and 22 Ralstonia strains and
the expected amplicons were obtained for all strains analyzed. Sequencing of ampli-
cons conﬁrmed the correct ampliﬁcation. All other Gram-negative nonfermenting
species tested remained negative, with the interesting exception of Cupriavidus
(Wautersia) respiraculi, previously regarded as belonging to the genus Ralstonia,
which was positive with the general primer but not with the two species speciﬁc
primers.
